production
Skip to Content

MT5024: MOLECULAR PHARMACOLOGY (2018-2019)

Last modified: 22 May 2019 17:07


Course Overview

The course focuses on the molecular mechanisms of drug action and how cutting edge research can advance current therapeutic approaches to disease.   The utility of molecular pharmacology will be highlighted in the context of current and future drug discovery for cardiovascular, neurological and metabolic diseases and cancer. 

Course Details

Study Type Postgraduate Level 5
Term First Term Credit Points 15 credits (7.5 ECTS credits)
Campus None. Sustained Study No
Co-ordinators
  • Dr Fiona Murray

What courses & programmes must have been taken before this course?

  • One of Any Postgraduate Programme (Studied) or MSc Clinical Pharmacology (Studied) or MSc Drug Discovery and Development (Studied)

What other courses must be taken with this course?

None.

What courses cannot be taken with this course?

  • MT5008 Molecular Pharmacology (Studied)

Are there a limited number of places available?

No

Course Description

The course will cover the molecular mechanisms of drug action and provide examples of how knowledge of the pathophysiology of disease can yield novel drug targets. Topics covered will included drug-receptor theory, signal transduction and pharmacogenomics.


Contact Teaching Time

Information on contact teaching time is available from the course guide.

Teaching Breakdown

More Information about Week Numbers


Details, including assessments, may be subject to change until 30 August 2024 for 1st term courses and 20 December 2024 for 2nd term courses.

Summative Assessments

Multiple Choice Questions (10%); Data handling  (10%); Extended practical report  (30%); Problem 1 (25%); Case study analysis  (25%).

Formative Assessment

There are no assessments for this course.

Feedback

Significant feedback will be provided for assessed exercises

Course Learning Outcomes

None.

Compatibility Mode

We have detected that you are have compatibility mode enabled or are using an old version of Internet Explorer. You either need to switch off compatibility mode for this site or upgrade your browser.